Day: September 26, 2024

– Morgan Conn, Ph.D., seasoned biotech executive with expertise in financing, business development, and corporate strategy, appointed as Chief Financial Officer – – Chad Cowan, Ph.D., cell therapy pioneer, founder, and former CEO of Clade Therapeutics, appointed as Chief Scientific Officer – – Hy Levitsky, M.D., President of Research and Development, to transition to an advisor to Century – PHILADELPHIA, Sept. 26, 2024 (GLOBE NEWSWIRE) — Century Therapeutics, Inc. (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology and autoimmune disease, today announced the appointments of Morgan Conn, Ph.D., as Chief Financial Officer and Chad Cowan, Ph.D., as Chief Scientific Officer. The appointments are effective October...

Figure 1 – QV Property Location MapFigure 1 – QV Property Location MapFigure 2 – Chris Creek 2024 Rock Sampling and Drilling RegionFigure 2 – Chris Creek 2024 Rock Sampling and Drilling RegionFigure 3 – Chris Creek Trend Soil Anomaly (Au, Mo, Hg, Te, Sb, As)Figure 3 – Chris Creek Trend Soil Anomaly (Au, Mo, Hg, Te, Sb, As)Figure 4 – QV Property OverviewFigure 4 – QV Property OverviewFigure 5 – ChrisCreek-VG-GS ComparisonFigure 5 – ChrisCreek-VG-GS ComparisonTORONTO, Sept. 26, 2024 (GLOBE NEWSWIRE) — White Gold Corp. (TSX.V: WGO, OTCQX: WHGOF, FRA: 29W) (the “Company”) is pleased to announce that surface rock sampling has encountered gold with associated anomalous silver and tellurium in altered and mineralized intrusive rocks...

Vancouver, British Columbia, Sept. 26, 2024 (GLOBE NEWSWIRE) — Surge Copper Corp. (TSXV: SURG) (OTCQB: SRGXF) (Frankfurt: G6D2) (“Surge” or the “Company”) is pleased to announce the successful completion of its 2024 field program at its 100%-owned Berg and Ootsa copper-molybdenum-precious metals projects located in central British Columbia. Field crews have now been demobilized, and with the conclusion of physical operations, the Company is ramping down associated expenditures as it transitions into the data analysis and reporting phase. 2024 Field Program HighlightsCompleted a total of 13 diamond drill holes for 5,054 metres:At the Berg Project, 10 holes were drilled for a total of 3,707 metres within the main Berg deposit, with an additional 450-metre hole testing the Berg SW exploration target. At the Ootsa Project, two...

SmartGateway Systems will be Deployed to Protect Patrons and Elevate their Ingress Experience TORONTO, Sept. 26, 2024 (GLOBE NEWSWIRE) — Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”), a leading technology-driven threat detection and security solution that prioritizes the patron access experience by leveraging AI, today announced that its SmartGateway screening solution was selected to secure UBS Arena in New York. This contract is enabled through the Company’s partnership with Oak View Group (OVG), a global sports and entertainment company. UBS Arena, an 18,000-seat capacity venue located in New York’s historic Belmont Park, is home to the National Hockey League’s (NHL) New York Islanders. Xtract One will provide fast and frictionless fan screening to optimize UBS Arena’s patron experience...

Agreement provides MSD with options to license Evaxion’s preclinical, AI-designed vaccine candidates EVX-B2 and EVX-B3 Evaxion will host a conference call and webcast to discuss the agreement on September 27, 2024COPENHAGEN, Denmark, Sept. 26, 2024 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced that it has entered into an option and license agreement with MSD (tradename of Merck & Co., Inc., Rahway, NJ, USA) for two preclinical vaccine candidates. The agreement expands the companies’ current collaboration and carries significant value for Evaxion. Under the terms of the agreement, Evaxion has granted MSD an option to exclusively license Evaxion’s preclinical vaccine candidates EVX-B2 and...

Business recognized for significant market impact and expansion of capabilities TROY, Mich., Sept. 26, 2024 (GLOBE NEWSWIRE) — Kelly Engineering® has been named a Leader and Star Performer on Everest Group’s 2024 PEAK Matrix® Assessment for US Engineering Contingent Talent and Strategic Solutions. This marks the third consecutive year Kelly has been recognized as a Leader in the engineering category. Among the engineering staffing providers evaluated by Everest Group, Kelly earned the highest marks for vision and capability, which measure its ability to deliver services to clients successfully. The PEAK Matrix provides an objective, data-driven assessment of US contingent workforce providers based on their market impact, vision, and capability. Providers are assessed in seven categories: market adoption, portfolio mix, value delivered,...

Houston-based aircraft brokerage EMCJET will showcase the Lilium Jet for the very first time in the U.S. at Galaxy FBO Galaxy FBO is partnering with Lilium to ensure accessibility for the Lilium Jet at their Houston-area facilities – Houston Hobby Airport, Conroe North Houston Regional Airport, and The Woodlands Heliport Lilium is collaborating with The Greater Houston Partnership to host a discussion with industry leaders on how electric aviation will revolutionize regional travel in the Houston areaHOUSTON, Sept. 26, 2024 (GLOBE NEWSWIRE) — Lilium (NASDAQ: LILM), a leading electric aircraft manufacturer and pioneer in Regional Air Mobility (RAM), is today debuting the Lilium Jet, the world’s first fully electric jet that can take off and land vertically, to the U.S. market. The Lilium Jet is designed and optimized for...

MONTREAL, Sept. 26, 2024 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced the Company will report financial results and provide a business update for its third quarter ended August 31, 2024, on Thursday, October 10 at 8:30 a.m. ET. The call will be hosted by Paul Lévesque, President and Chief Executive Officer. He will be joined by other members of the management team, including Philippe Dubuc, Senior Vice President and Chief Financial Officer, Christian Marsolais, Ph.D., Senior Vice President and Chief Medical Officer and John Leasure, Global Commercial Officer who will be available to answer questions from participants following prepared remarks. Participants...

New Partnership Builds AI-Driven Healthcare Billing Solutions for U.S. Nursing Homes.Streamlining Healthcare Management for Nursing HomesSimplified Billing and Improved Care with Burst Medical Billing Solutions for Streamlining Healthcare Management in Nursing Homes.LAS VEGAS, Sept. 26, 2024 (GLOBE NEWSWIRE) — Tritent International Corp. (“Tritent”), a US public company (US OTC: TICJ), and Burst Technologies, Inc. (“Burst Technologies”), a Delaware corporation, are pleased to announce the signing of a Memorandum of Understanding (“MOU”) that outlines the key terms and conditions for a proposed strategic merger. The MOU was officially executed on September 24, 2024. In a groundbreaking move to enhance healthcare billing efficiency, Burst Technologies and Tritent are excited to announce...

WOBURN, Mass., Sept. 26, 2024 (GLOBE NEWSWIRE) — iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today that it has secured a $1 million loan agreement and subsequently appointed three new members to its Board of Directors. On September 25, 2024, iSpecimen closed a $1 million loan agreement with a lender which carries an interest rate of 18% per annum and is payable within 12 months of issuance. The agreement obligates the lender to provide iSpecimen with a revolving line of credit of up to $1 million upon the Company’s initial filing of a Registration Statement for a public offering with gross proceeds of at least $5 million. Westpark Capital, Inc. served...